LFM-A13

Modify Date: 2025-08-27 14:19:28

LFM-A13 structure	Common Name	LFM-A13
	CAS Number	62004-35-7	Molecular Weight	360.00
	Density	1.9±0.1 g/cm3	Boiling Point	487.9±45.0 °C at 760 mmHg
	Molecular Formula	C₁₁H₈Br₂N₂O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	248.9±28.7 °C

Use of LFM-A13

LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 μM, 10 μM and 61 μM. LFM-A13 has antiproliferative activity and anticancer activity. LFM-A13 can be used in cancer-related research[1][3][4]

Name	LFM-A13,2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
Synonym	More Synonyms

Description	LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 μM, 10 μM and 61 μM. LFM-A13 has antiproliferative activity and anticancer activity. LFM-A13 can be used in cancer-related research[1][3][4]
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Signaling Pathways >> Cell Cycle/DNA Damage >> Polo-like Kinase (PLK) Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
Target	Plx1:10 μM (IC50) PLK3:61 μM (IC50) BRK:267 μM (IC50) BMX:281 μM (IC50) FYN:240 μM (IC50) Met:215 μM (IC50) Btk:2.5 μM (IC50)
References	[1]. Mahajan S, et al. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. J Biol Chem. 1999 Apr 2;274(14):9587-99. [2]. van den Akker E, et al. The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity. Biol Chem. 2004 May;385(5):409-13. [3]. Uckun FM, et al. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK). Bioorg Med Chem. 2007 Jan 15;15(2):800-14. [4]. Sahin K, et al. LFM-A13, a potent inhibitor of polo-like kinase, inhibits breast carcinogenesis by suppressing proliferation activity and inducing apoptosis in breast tumors of mice. Invest New Drugs. 2018 Jun;36(3):388-395.

Density	1.9±0.1 g/cm3
Boiling Point	487.9±45.0 °C at 760 mmHg
Molecular Formula	C₁₁H₈Br₂N₂O₂
Molecular Weight	360.00
Flash Point	248.9±28.7 °C
Exact Mass	357.895233
PSA	73.12000
LogP	3.42
Vapour Pressure	0.0±1.3 mmHg at 25°C
Index of Refraction	1.677
InChIKey	UVSVTDVJQAJIFG-SOFGYWHQSA-N
SMILES	CC(O)=C(C#N)C(=O)Nc1cc(Br)ccc1Br

Hazard Codes	Xn
Risk Phrases	20/21/22
Safety Phrases	36/37

2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-, (2Z)-

a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide

(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide

trans-4,5-didehydro-neral

dehydrocitral

trans-dehydroneral

2,4,6-Octatrienal,3,7-dimethyl

(2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: LFM-A13
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Get all suppliers and price by the below link:

LFM-A13 suppliers

LFM-A13 price

LFM-A13

Use of LFM-A13

Names

LFM-A13 Biological Activity

Chemical & Physical Properties

Safety Information

Synonyms

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.